Herceptin Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: Trastuzumab deruxtecan;   Drug: Docetaxel;   Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Trastuzumab;   Drug: Pertuzumab;   Drug: Ribociclib;   Drug: Letrozole;   Drug: Epirubicin;   Drug: Cyclophosphamide Sponsor:   Karolinska University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 12, 2023 Category: Research Source Type: clinical trials